United Health Products, Inc.
UEEC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 63,459.3% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 50.3% | 57.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -4,278.9% | -50,730,393.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -4,500% | -51,778,276.3% |
| EPS Diluted | -0.008 | -0.011 | -0.007 | -0.14 |
| % Growth | 26.4% | -50.7% | 94.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |